Question

Dense text please

Think of your current job, a previous job or the job that you want tomorrow.

figure out where you can find the cleanest data in order to figure out how your business should respond (depending on your particular business) and position itself. Where will you look? Why? How will you analyze it? how covid had impacted the medical business

500 words, please

Answer 1

Answer :

The job i want to do tomorrow is the job of a Investment Banking. An investment bank is a financial services company or corporate division that engages in advisory-based financial transactions on behalf of individuals, corporations, and governments. Traditionally associated with corporate finance, such a bank might assist in raising financial capital by underwriting or acting as the client's agent in the issuance of securities. An investment bank may also assist companies involved in mergers and acquisitions (M&A) and provide ancillary services such as market making, trading of derivatives and equity securities, and FICC services (fixed income instruments, currencies, and commodities). Most investment banks maintain prime brokerage and asset management departments in conjunction with their investment research businesses. As an industry, it is broken up into the Bulge Bracket (upper tier), Middle Market (mid-level businesses), and boutique market (specialized businesses).

The cleanest data regarding investment banking can be gathered from various companies engaged in investment banking by analysing there data from wide sources like websites, business magazines, and from there financial statements. Few top companies in investment banking are J.P. Morgan, Barclays Capital, Deutsche Bank etc.. A person can get cleanest data from here by analysing there financials.

The future of investment banking is bright as we know that finance is the blood for any business or industry due to this the need for investment banking will always exist because one needs finance at every point of life.

Impact of Covid on Medical Business :

Health care has been relatively immune from recessions. People get sick during both good and bad times, so demand for medical care is relatively constant across the business cycle. Furthermore, health insurance reduces the out-of-pocket costs for care that people face; thus, many sick people—at least those with health insurance—can still afford to visit physicians.

However, the COVID-19 recession is shaping up to be different. For starters, people are being asked to curtail outside activities. This is particularly true for those who have medical conditions that put them at higher risk—the type of individuals who use health care the most. On top of this is the desire to keep medical offices clear to reduce the risk of being a point of disease spread. In addition, the insurance that privately insured patients have today is less generous than it was during past recessions. More than one-quarter of those with private insurance have an insurance policy with a deductible of $2000 or more, 4 times the percentage of people who had a deductible that high one decade ago. With cash tight, people will postpone all kinds of care, from office visits to imaging procedures to filling prescriptions for medications.

Overall, the Covid-19 pandemic is expected to have minimal impact on lifesaving cardiovascular procedures. For example, some procedures are considered urgent in treating acute myocardial infarction or a heart attack.

Despite the current crisis being a healthcare issue, the private healthcare system in the world continues to reel under the negative impact of COVID-19. There has been a significant drop in both in-patient and out-patient footfall for private hospital chains—be it a single speciality, multi-speciality, tertiary-care hospitals or even diagnostics businesses, during this lockdown.

With no immediate sign of the pandemic regressing, the situation can become tense. Hospitals across segments—big or small—have limited reserves and require support from the government.

In the light of ongoing disruption spurred by COVID-19, most companies would have to adopt new business models and philosophies for better management of potential outbreaks in future. Countries with enormous healthcare spending are likely to benefit from this pandemic. Companies are escalating the production of diagnostic tests and therapeutics in the race to effectively identify and treat patients suffering from this highly communicable respiratory disease. Eventually, the company which successfully develops and launches vaccine for COVID-19 would cross the finish line. However, a commercially viable vaccine is still 12-18 months away. Leading pharmaceutical companies are receiving impetus from governments to accelerate the human trials of vaccine.

Besides, other companies which are likely to benefit from this pandemic are those which produce ventilators, hospital beds, face masks, safety gears, and other medical equipment. However, with numerous countries banning the export of medical equipment, the global supply chain has been severely affected. The domestic production on the other hand continues to surge with several entrepreneurs offering to manufacture medical gears and equipment.